Director Paul A. Ainsworth will be speaking at ACI’s 10th anniversary edition of their Biosimilars Summit in New York, New York on Monday, June 24, 2019. Paul will be speaking on the panel “The ITC: Examining the Role of this Alternate Forum in Biosimilars Disputes.”

Topic discussion:

  • Exploring the ITC as a venue for reaching a relatively swifter and earlier resolution of a biosimilars challenge
  • Weighing the pros and cons of avoiding the patent dance and assessing the benefits of asserting any number of claims in lieu of the aBLA process
  • Capitalizing on the benefit of receiving remedies beyond the restrictions imposed by the district courts

Related Professionals

Related Services